Indoco Remedies Limited
Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
What Indoco files
- Others55
- Investor Meet40
- Important24
- Updates17
- Board Meeting6
- Dividend/Bonus4
Indoco Remedies successfully completed a UK MHRA inspection at its Goa solid oral dosage manufacturing facility with zero critical or major observations. This key facility drives significant international business, reinforcing compliance standards and ensuring uninterrupted global market supply.
Indoco Remedies' Goa sterile facility received 7 USFDA observations during a recent inspection. The company is actively addressing these findings and will respond to the USFDA. Investors should monitor progress on these operational issues.
Indoco Remedies sold a 2,876.08 sq meter plot of land to Kalpataru Townships for Rs. 64.00 Cr. This transaction is expected to have no impact on the company's core business operations.
Indoco Remedies Limited has informed the Exchange about Newspaper Advertisement regarding Notice convening the 79th AGM and E-voting Information
Indoco Remedies significantly advanced sustainability in FY26. Renewable energy reached 43.5% of total consumption, with net Scope 1 & 2 GHG emissions down 8.8% and water withdrawal reduced by 16.7%. Its Patalganga API site achieved an EcoVadis Bronze rating. The company also converted a 107.50 Cr loan to a subsidiary...